tions among vast genetic changes as a strategy to target tumor cell vulnerabilities with novel therapies. The application of siRNA technology to induce therapeutic functional changes in gene expression in glioblastoma multiforme cells is described in the article by Thaker et al. In the remaining articles the authors discuss genetic and proteomic changes associated with specific diseases, including head trauma (Dardiotis et al.), Parkinson disease (Hadjigeorgiou et al.), and neurofibromatosis Type 1 (Gottfried et al.). Dhandapani et al. discuss their novel proteomic studies in patients with subarachnoid hemorrhage, which provide proof of principle and promise for future development of diagnostic and therapeutic innovations in this emerging and fascinating area of research. Finally, Vannemreddy and colleagues provide data supporting a role for eNOS in the clinical presentation of intraventricular hemorrhage. Collectively, these papers serve as a solid primer in genomics and proteomics for the practicing neurosurgeon and convey some of the most exciting recent molecular science developments relevant to neurosurgical disease.
